Related Experiment Video
Updated: Mar 15, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Impact of clinical input variable uncertainties on ten-year atherosclerotic cardiovascular disease risk using new
Himanshu Gupta1,2, Chun G Schiros3, Oleg F Sharifov3
1Department of Medicine, Cardiovascular Disease, University of Alabama at Birmingham, 1808 7th Ave South, BDB 101, Birmingham, AL, 35294, USA. hgupta@uab.edu.
Insights
Clinical variable uncertainties can change atherosclerotic cardiovascular risk estimates. Healthcare providers should discuss these variations and improve measurement accuracy for better patient care under new guidelines.
Area of Science:
- Cardiology
- Public Health
- Biostatistics
Background:
- The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend Pooled Cohort equations for atherosclerotic cardiovascular risk assessment.
- The influence of uncertainties in clinical input variables on these ten-year cardiovascular risk estimates remains unexamined.
Purpose of the Study:
- To quantify the impact of clinical input variable uncertainties on ten-year atherosclerotic cardiovascular risk estimates.
- To analyze how variations in age, cholesterol levels, and blood pressure affect risk categorization based on ACC/AHA guidelines.
Main Methods:
- Utilized the National Health and Nutrition Examination Survey dataset (2005-2010).
- Calculated maximum and minimum ten-year cardiovascular risks by introducing clinically relevant variations in age, total cholesterol, HDL cholesterol, and systolic blood pressure.
- Assessed changes in risk category at 5% and 7.5% risk limits, which guide drug therapy decisions.
Main Results:
- Up to 24% of the population cohort experienced a change in risk category due to input variable uncertainties at both 5% and 7.5% risk thresholds.
- This effect was consistent across subgroups, with African American males showing a high baseline risk irrespective of variable variations.
Conclusions:
- Uncertainties in clinical variables significantly impact atherosclerotic cardiovascular risk categorization.
- Accurate measurement of clinical variables and standardized laboratory parameters are crucial for implementing ACC/AHA guidelines effectively.
- Future risk calculators should allow customization to accommodate individual patient circumstances.
Background:
Recently released American College of Cardiology/American Heart Association (ACC/AHA) guideline recommends the Pooled Cohort equations for evaluating atherosclerotic cardiovascular risk of individuals. The impact of the clinical input variable uncertainties on the estimates of ten-year cardiovascular risk based on ACC/AHA guidelines is not known.
Methods:
Using a publicly available the National Health and Nutrition Examination Survey dataset (2005-2010), we computed maximum and minimum ten-year cardiovascular risks by assuming clinically relevant variations/uncertainties in input of age (0-1 year) and ±10 % variation in total-cholesterol, high density lipoprotein- cholesterol, and systolic blood pressure and by assuming uniform distribution of the variance of each variable. We analyzed the changes in risk category compared to the actual inputs at 5 % and 7.5 % risk limits as these limits define the thresholds for consideration of drug therapy in the new guidelines. The new-pooled cohort equations for risk estimation were implemented in a custom software package.
Results:
Based on our input variances, changes in risk category were possible in up to 24 % of the population cohort at both 5 % and 7.5 % risk boundary limits. This trend was consistently noted across all subgroups except in African American males where most of the cohort had ≥7.5 % baseline risk regardless of the variation in the variables.
Conclusions:
The uncertainties in the input variables can alter the risk categorization. The impact of these variances on the ten-year risk needs to be incorporated into the patient/clinician discussion and clinical decision making. Incorporating good clinical practices for the measurement of critical clinical variables and robust standardization of laboratory parameters to more stringent reference standards is extremely important for successful implementation of the new guidelines. Furthermore, ability to customize the risk calculator inputs to better represent unique clinical circumstances specific to individual needs would be highly desirable in the future versions of the risk calculator.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Relative Risk
Confounding in Epidemiological Studies
